Candida albicans and candidalysin in inflammatory disorders and cancer.
Candida albicans and candidalysin in inflammatory disorders and cancer.
复制标题
DOI:
10.1111/imm.13255
复制
发表时间:
2021-01
期刊:
影响因子:
6.4
通讯作者:
Naglik JR
中科院分区:
文献类型:
--
作者:
Ho J;Camilli G;Griffiths JS;Richardson JP;Kichik N;Naglik JR
As our understanding of mycology progresses, the impact of fungal microbes on human health has become increasingly evident. Candida albicans is a common commensal fungus that gives rise to local and systemic infections, particularly in immunocompromised patients where it can result in mortality. However, C. albicans has also been quietly linked with a variety of inflammatory disorders, to which it has traditionally been considered incidental; recent studies may now provide new aspects of these relationships for further consideration. This review provides a novel perspective on the impact of C. albicans and its peptide toxin, candidalysin, on human health, exploring their contributions to pathology within a variety of diseases. Candida albicans infections have been linked with a variety of inflammatory diseases. The ability for C. albicans to potentiate pathology in these instances is explored in this review.